Acadia Pharmaceuticals has announced an indefinite delay in its plans to seek approval for its Rett syndrome drug, Daybue, in the United Kingdom. This decision stems...
An estimated 10,000 ankle replacements are performed annually in the United States. A surgeon from New York City has introduced a patented technique that aims to...
The Swedish biopharmaceutical company Alzinova has received approval from the U.S. Food and Drug Administration (FDA) to advance its Alzheimer’s vaccine candidate, ALZ-101, into a Phase...
Ice Cream Factory, based in Mount Vernon, New York, has initiated an urgent recall of its Vanilla G.Nutt flavour due to a serious health risk associated...
Dozens of pints of vanilla ice cream have been recalled due to the presence of an undeclared allergen, posing a serious health risk for certain consumers....
The U.S. Food and Drug Administration (FDA) has announced a significant change in its reporting practices by providing daily updates on adverse event data. This initiative...
The U.S. Food and Drug Administration (FDA) has issued new draft guidance that mandates the inclusion of overall survival (OS) data in all randomized clinical trials...
The U.S. Food and Drug Administration (FDA) has issued new draft guidance requiring that overall survival (OS) data be included in all randomized cancer drug clinical...
Sarepta Therapeutics has successfully completed a debt refinancing deal, allowing the biotechnology firm to restructure its financial obligations. This move comes amidst ongoing challenges with the...
Sarepta Therapeutics has successfully refinanced its debt, providing the biotech firm with a stronger financial footing as it navigates a complex regulatory landscape. This move comes...
